Fulgent Genetics Inc (FLGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -411 | -5,607 | -2,510 | -5,347 | -8,314 |
| Depreciation Amortization | 2,213 | 2,460 | 2,098 | 1,233 | 575 |
| Income taxes - deferred | -21 | 36 | -336 | 246 | N/A |
| Accounts receivable | -839 | -1,970 | 214 | -2,322 | -1,779 |
| Accounts payable and accrued liabilities | -329 | 102 | -363 | 1,094 | 132 |
| Other Working Capital | -915 | -1,244 | -714 | -1,857 | -1,748 |
| Other Operating Activity | 5,819 | 5,548 | 2,942 | 11,358 | 10,165 |
| Operating Cash Flow | $5,517 | $-675 | $1,331 | $4,405 | $-969 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -27,727 | 3,782 | -474 | -39,017 | N/A |
| PPE Investments | -1,182 | -2,832 | -5,356 | -3,778 | -2,030 |
| Purchase Of Investment | -137 | N/A | N/A | N/A | N/A |
| Sale Of Investment | 0 | N/A | 3,781 | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | 0 | -175 |
| Investing Cash Flow | $-29,046 | $950 | $-2,049 | $-42,795 | $-2,205 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 28,796 | 15 | 31 | 36,790 | 3,500 |
| Common Stock Repurchased | -21 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 0 | 0 | -801 | 8,999 | 0 |
| Financing Cash Flow | $28,775 | $15 | $-770 | $45,789 | $3,500 |
| Exchange Rate Effect | -17 | -44 | 81 | N/A | N/A |
| Beginning Cash Position | 6,736 | 6,490 | 7,897 | 498 | 172 |
| End Cash Position | 11,965 | 6,736 | 6,490 | 7,897 | 498 |
| Net Cash Flow | $5,229 | $246 | $-1,407 | $7,399 | $326 |
| Free Cash Flow | |||||
| Operating Cash Flow | 5,517 | -675 | 1,331 | 4,405 | -969 |
| Capital Expenditure | -1,182 | -2,832 | -5,356 | -3,788 | -2,100 |
| Free Cash Flow | 4,335 | -3,507 | -4,025 | 617 | -3,069 |